CKM and Hepatic steatosis: In summary, the CKM concept provides a vital foundation for vascular prevention, while our proposed LMV syndrome advances this framework by establishing hepatic steatosis as the pivotal trigger in metabolic-vascular pathogenesis, expanding disease scope to pan-metabolic vasculopathy (heart-brain-kidney-peripheral vessels), and as well, introducing liver-centric biomarkers for precision screening.